PMID- 31832439 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231019 IS - 2322-3480 (Print) IS - 2322-3480 (Electronic) IS - 2322-3480 (Linking) VI - 8 IP - 2 DP - 2019 Jul TI - The Association of HLA-A, B and DRB1 with Buerger's Disease. PG - 153-160 AB - BACKGROUND: Thromboangiitis obliterans (TAO), also known as Burger's disease, is a devastating disease affecting the arteries and veins of the upper and lower distal limbs most commonly afflicting young male smokers of low socioeconomic status. The expression of human leukocyte antigen (HLA)-A, B and -DRB1 genes have been implicated in the pathogenesis of TAO. Our study aimed to examine the association of different HLA-A, B and -DRB1 genes in TAO patients in the Iranian population. METHODS: A case-control study examining 55 Iranian patients with TAO and 500 healthy subjects was performed in Imam Reza hospital, Mashhad, Iran. The prevalence of major histocompatibility complex (MHC) class I (-A, -B) and class II (-DRB) alleles were determined for each participant. RESULTS: Our results revealed the HLA-A*03 (odds ratio [OR]=5.394), HLA-A*24 (OR=5.143), HLA-A*31 (OR=4.251), HLA-A*11 (OR=3.034), HLA-B*27 (OR=6.680), HLA-B*15 (OR=3.959), HLA-B*07 (OR=3.698), HLA-B*51 (OR=3.370), HLA-B*44 (OR=3.326), HLA-DRB1*16 (OR=20.583), HLADRB1* 04 (OR=8.960), HLA-DRB1*14 (OR=3.746), HLA-DRB1*03 (OR=2.303), and HLA-DRB1*15 (OR=2.111) alleles to occur at a significantly higher frequency in TAO patients compared to controls (p<0.05). The HLA-A*25, HLA-A*66, HLA-DRB1*08, HLA-DRB1*10, and HLA-DRB1*12 alleles resulted in infinite OR, and was associated with an increased risk of TAO. However, the alleles HLA-A*30, HLA-B*08, HLA-B*45, HLA-B*46, and HLA-B*53 were associated with a protective role against TAO with an OR = 0. CONCLUSION: This is the first study examining the HLA pattern in patients with Burger's disease in the Iranian population. Our findings have revealed an association between HLA class I and II alleles with TAO. FAU - Shapouri-Moghaddam, Abbas AU - Shapouri-Moghaddam A AD - Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Mohammadi, Mojgan AU - Mohammadi M AD - Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Rahimi, Hamid Reza AU - Rahimi HR AD - Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Esmaeili, Habibolah AU - Esmaeili H AD - Social Determination of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Mahmoudi, Mahmoud AU - Mahmoudi M AD - Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Saeed Modaghegh, Mohammad-Hadi AU - Saeed Modaghegh MH AD - Vascular and Endovascular Surgery Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Iran. FAU - Tavakol Afshari, Jalil AU - Tavakol Afshari J AD - Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. LA - eng PT - Journal Article PL - Iran TA - Rep Biochem Mol Biol JT - Reports of biochemistry & molecular biology JID - 101637937 PMC - PMC6844607 OTO - NOTNLM OT - Buerger's disease OT - HLA-DNA typing OT - MHC OT - Polymerase chain reaction OT - Thromboangiitis obliterans EDAT- 2019/12/14 06:00 MHDA- 2019/12/14 06:01 PMCR- 2019/07/01 CRDT- 2019/12/14 06:00 PHST- 2019/12/14 06:00 [entrez] PHST- 2019/12/14 06:00 [pubmed] PHST- 2019/12/14 06:01 [medline] PHST- 2019/07/01 00:00 [pmc-release] AID - rbmb-8-153 [pii] PST - ppublish SO - Rep Biochem Mol Biol. 2019 Jul;8(2):153-160.